rs144422014
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM1BP4_ModerateBA1
The NM_002769.5(PRSS1):āc.161A>Gā(p.Asn54Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0485 in 1,008,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_002769.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRSS1 | NM_002769.5 | c.161A>G | p.Asn54Ser | missense_variant | 2/5 | ENST00000311737.12 | NP_002760.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRSS1 | ENST00000311737.12 | c.161A>G | p.Asn54Ser | missense_variant | 2/5 | 1 | NM_002769.5 | ENSP00000308720 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 23289AN: 83508Hom.: 0 Cov.: 32 FAILED QC
GnomAD4 exome AF: 0.0485 AC: 48932AN: 1008258Hom.: 0 Cov.: 61 AF XY: 0.0541 AC XY: 26862AN XY: 496076
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.279 AC: 23329AN: 83602Hom.: 0 Cov.: 32 AF XY: 0.273 AC XY: 11220AN XY: 41066
ClinVar
Submissions by phenotype
Hereditary pancreatitis Pathogenic:1Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 19, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2005 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2015 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at